Effects of Aliskiren on Blood Pressure, Albuminuria, and (Pro)Renin Receptor Expression in Diabetic TG(mRen-2)27 Rats-Reference-Cited by-同舟云学术

Effects of Aliskiren on Blood Pressure, Albuminuria, and (Pro)Renin Receptor Expression in Diabetic TG(mRen-2)27 Rats

Published:2008-07 Issue:1 Volume:52 Page:130-136
ISSN:0194-911X
Container-title:Hypertension
language:en
Short-container-title:Hypertension

Author:

Feldman David L.¹,Jin Liang¹,Xuan Hong¹,Contrepas Aurelie¹,Zhou Yinong¹,Webb Randy L.¹,Mueller Dominik N.¹,Feldt Sandra¹,Cumin Frederick¹,Maniara Wieslawa¹,Persohn Elke¹,Schuetz Helmut¹,Jan Danser A.H.¹,Nguyen Genevieve¹

Affiliation:

1. From Novartis Institutes for Biomedical Research (D.L.F., L.J., H.X., Y.Z., R.L.W., F.C., W.M.), E. Hanover, NJ and Cambridge, Mass; Inserm Unit 833 (A.C., G.N.), Paris, France; Chaire de Médecine Expérimentale (A.C., G.N.), Collège de France, Paris, France; Max-Delbruck-Center (D.N.M., S.F.), Berlin-Buch, Germany; Novartis Pharma AG (E.P., H.S.), Basel, Switzerland; and the Department of Pharmacology (A.H.J.D.), Erasmus MC, Rotterdam, The Netherlands.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Internal Medicine

Reference29 articles.

1. The Effect of Angiotensin-Converting-Enzyme Inhibition on Diabetic Nephropathy

2. Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Nephropathy

3. Aliskiren, a Novel Orally Effective Renin Inhibitor, Provides Dose-Dependent Antihypertensive Efficacy and Placebo-Like Tolerability in Hypertensive Patients

4. Blood Pressure Lowering in Essential Hypertension With an Oral Renin Inhibitor, Aliskiren

5. Aliskiren, a Human Renin Inhibitor, Ameliorates Cardiac and Renal Damage in Double-Transgenic Rats

Cited by 255 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Capybara Oil Improves Renal Pathophysiology and Inflammation in Obese Mice;Nutrients;2023-06-28

2. Sex differences in the renin-angiotensin-aldosterone system and its roles in hypertension, cardiovascular, and kidney diseases;Frontiers in Cardiovascular Medicine;2023-06-19

3. Effects of Aliskiren Monotherapy versus Amlodipine Monotherapy in Hypertensive Patients with Obesity or Type 2 Diabetes Mellitus;Kidney and Blood Pressure Research;2023

4. Sodium–glucose cotransporter inhibitors and kidney fibrosis: review of the current evidence and related mechanisms;Pharmacological Reports;2022-12-19

5. Blood pressure‐independent renoprotective effects of small interference RNA targeting liver angiotensinogen in experimental diabetes;British Journal of Pharmacology;2022-10-02